Integrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biology
Open Access
- 24 October 2025
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (2) , 505-519
Abstract
Background: Medulloblastoma and ependymoma are common pediatric central nervous system tumors with significant molecular and clinical heterogeneity. While molecular subgrouping has enabled classification into molecular subtypes, the extent of heterogeneity within these subgroups remains poorly defined. Methods: We collected bulk RNA sequencing data from 888 medulloblastoma and 370 ependymoma tumors to establish a comprehensive reference landscape. After rigorous batch effect correction, normalization, and dimensionality reduction, we generated a unified landscape to explore gene expression, signaling pathways, RNA fusions, and copy number variations. Results: Our transcriptional analysis revealed distinct clustering patterns, including two primary ependymoma compartments, EPN-E1 and EPN-E2, each with specific RNA fusions and molecular signatures. In medulloblastoma, we observed precise stratification of Group 3/4 tumors by subtype and in Sonic Hedgehog (SHH) tumors by patient age. We also identified subtype-specific pathways and gene fusions, enriched in each group. Conclusions: This transcriptomic landscape serves as a resource for biomarker discovery, diagnostic refinement, and prediction of tumor biology and outcome. By enabling projection of new patients’ bulk RNA-seq data onto the reference map using nearest neighbor analysis, the framework supports accurate subtype classification. The landscape is publicly available via Oncoscape, an interactive platform for global exploration and application.Keywords
All Related Versions
Funding Information
- National Institutes of Health (1R35 CA253119-01A1)
- National Institutes of Health (U54 CA243125)
- National Institutes of Health (C11orf95)
- RELA fusion-driven ependymoma
- Fred Hutchinson Cancer Center (1R35 CA253119-01A1)
This publication has 49 references indexed in Scilit:
- C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymomaNature, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- The sva package for removing batch effects and other unwanted variation in high-throughput experimentsBioinformatics, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- Gene Expression Patterns in Ependymomas Correlate with Tumor Location, Grade, and Patient AgeThe American Journal of Pathology, 2003
- MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.2001
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000